Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ZCCN INFO
832171
5
JILIN TANGU
836077
CN Stock MarketDetailed Quotes
002551 Shenzhen Glory Medical
- 4.39
- +0.40+10.03%
Not Open May 14 15:00 CST
3.71BMarket Cap168.85P/E (TTM)
4.39High4.33Low1.16MlotVolume4.39Open3.99Pre Close509.42MTurnover18.99%Turnover Ratio168.85P/E (Static)845.49MShares4.3952wk High1.40P/B2.68BFloat Cap2.2352wk Low4.39Limit Up611.02MShs Float34.20Historical High3.59Limit Down1.50%Amplitude2.11Historical Low--Dividend TTM4.39Avg Price980.40KlotAsk--Div YieldTTM100Lot Size86.91KlotBid
Shenzhen Glory Medical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.30%279.74M | 21.40%1.45B | 9.13%1B | 5.25%631.46M | -10.75%276.14M | -6.49%1.19B | -2.26%918.8M | -4.40%599.98M | -36.08%309.4M | -28.74%1.28B |
| Operating revenue | 1.30%279.74M | 21.40%1.45B | 9.13%1B | 5.25%631.46M | -10.75%276.14M | -6.49%1.19B | -2.26%918.8M | -4.40%599.98M | -36.08%309.4M | -28.74%1.28B |
| Other operating revenue | ---- | 1.94%3.69M | ---- | 104.72%7M | ---- | -56.28%3.62M | ---- | 25.52%3.42M | ---- | -49.92%8.27M |
| Total operating cost | 5.60%283.91M | 14.34%1.39B | 7.88%990.95M | 4.66%625.94M | -12.12%268.85M | -6.83%1.21B | -6.80%918.58M | -9.86%598.09M | -36.56%305.92M | -24.51%1.3B |
| Operating cost | 4.42%237.02M | 19.46%1.19B | 13.23%843.83M | 10.84%535M | -9.04%227M | -5.56%995.28M | -2.22%745.25M | -7.25%482.69M | -39.90%249.56M | -28.02%1.05B |
| Operating tax surcharges | 28.04%5.72M | 11.56%22.47M | 4.19%15.27M | 4.90%9.91M | -1.70%4.47M | 8.88%20.14M | 13.38%14.66M | 7.36%9.45M | 13.72%4.55M | -18.08%18.5M |
| Operating expense | 22.94%3.82M | -33.30%16.07M | -20.29%11.45M | -21.50%7.4M | -63.06%3.11M | -2.37%24.1M | -71.17%14.36M | -71.13%9.42M | -48.80%8.41M | -50.60%24.68M |
| Administration expense | -11.16%33.92M | -5.89%132.99M | -9.40%107.86M | -16.92%66.93M | -12.71%38.18M | -2.54%141.32M | 5.01%119.05M | 6.48%80.56M | 15.64%43.74M | 10.24%145M |
| Financial expense | -7.24%-6.64M | -69.24%-16.22M | -225.60%-16.65M | -271.34%-10.63M | -146.21%-6.2M | -195.98%-9.58M | -138.12%-5.11M | -156.83%-2.86M | -289.31%-2.52M | 432.87%9.99M |
| -Interest expense (Financial expense) | 2,094.07%968.48K | 191.12%5.83M | -2.76%1.79M | -1.05%979.51K | -83.16%44.14K | -54.95%2M | 8.68%1.84M | -41.51%989.91K | 0.43%262.06K | -38.48%4.44M |
| -Interest Income (Financial expense) | 48.07%-1.48M | -23.31%-10.76M | -58.20%-7.71M | -81.41%-4.94M | -136.55%-2.85M | -25.81%-8.73M | -120.23%-4.88M | -22.91%-2.72M | -221.77%-1.2M | -33.83%-6.94M |
| Research and development | 340.47%10.06M | 1.77%40.78M | -3.93%29.18M | -7.97%17.33M | 5.16%2.28M | -16.83%40.07M | -10.33%30.37M | -10.05%18.83M | -70.60%2.17M | -7.99%48.18M |
| Credit Impairment Loss | 377.25%25.8M | 42.25%-29.84M | -397.73%-7.58M | 130.22%476.38K | 77.28%5.41M | 73.19%-51.66M | 121.43%2.55M | 89.20%-1.58M | -73.80%3.05M | -538.01%-192.71M |
| Asset Impairment Loss | 103.93%9.92K | 86.39%-9.15M | --1.55M | --1.49M | ---252.04K | 64.70%-67.29M | ---- | ---- | ---- | -7,499.44%-190.61M |
| Other net revenue | 288.78%28.76M | 71.18%-29.62M | -106.30%-678.27K | 1,325.66%7.95M | 72.09%7.4M | 71.61%-102.78M | 6,044.81%10.76M | 92.72%-648.78K | -72.91%4.3M | -5,903.94%-362.07M |
| Fair value change income | -252.53%-919.64K | 337.72%1.32M | 1,840.51%816.28K | -94.10%51.08K | -174.64%-260.87K | -121.45%-556.45K | -101.01%-46.9K | -60.21%865.3K | -73.09%349.5K | 13.12%2.59M |
| Invest income | 96.68%2.96M | -68.64%2.7M | -35.76%1.48M | 200.92%4.08M | 2,620.27%1.51M | -19.56%8.61M | 256.34%2.3M | -997.65%-4.04M | -111.11%-59.81K | -59.19%10.71M |
| -Including: Investment income associates | 99.45%-1.72K | 723.03%485.06K | -339.27%-2.46M | 301.02%1.12M | -426.16%-314.68K | -106.91%-77.85K | -69.23%-558.92K | -17.60%-558.92K | -113.84%-59.81K | -72.79%1.13M |
| Asset deal income | --3.11K | 594.75%124.83K | --79.58K | --80.03K | ---- | ---25.23K | ---- | ---- | ---- | ---- |
| Other revenue | -9.63%900.76K | -35.83%5.22M | -50.10%2.98M | -56.57%1.78M | 3.89%996.75K | 2.49%8.14M | -31.75%5.97M | -38.09%4.1M | -59.88%959.41K | -24.05%7.94M |
| Operating profit | 67.36%24.59M | 127.67%33.54M | 0.34%11.01M | 989.79%13.47M | 88.84%14.69M | 68.64%-121.22M | 123.99%10.98M | 102.76%1.24M | -56.09%7.78M | -621.25%-386.55M |
| Add:Non operating Income | -97.53%187.93K | 111.63%6.22M | -8.07%10.08M | -6.04%10.01M | 971.10%7.62M | 18.58%2.94M | 1,681.45%10.96M | 2,088.78%10.65M | 5.27%711.58K | 389.94%2.48M |
| Less:Non operating expense | 877.15%242.22K | -34.25%6.15M | -84.73%537.58K | -79.75%215.18K | -88.66%24.79K | 2,940.17%9.36M | 1,648.47%3.52M | 1,809.55%1.06M | 447.12%218.59K | -17.71%307.91K |
| Total profit | 10.08%24.54M | 126.33%33.6M | 11.60%20.56M | 114.95%23.27M | 169.41%22.29M | 66.79%-127.64M | 140.62%18.42M | 124.39%10.82M | -54.93%8.27M | -617.40%-384.37M |
| Less:Income tax cost | 90.40%7.49M | -76.82%7.69M | 487.36%1.96M | 602.74%4.59M | 667.29%3.93M | 158.75%33.18M | 72.68%-506.21K | 65.16%-913.41K | -89.97%512.69K | -5,578.06%-56.47M |
| Net profit | -7.14%17.05M | 116.11%25.91M | -1.75%18.59M | 59.09%18.67M | 136.52%18.36M | 50.95%-160.82M | 143.52%18.93M | 128.11%11.74M | -41.40%7.76M | -547.60%-327.9M |
| Net profit from continuing operation | -7.14%17.05M | 116.11%25.91M | -1.75%18.59M | 59.09%18.67M | 136.52%18.36M | 50.95%-160.82M | 143.52%18.93M | 128.11%11.74M | -41.40%7.76M | -547.60%-327.9M |
| Less:Minority Profit | -31.09%3.08M | 130.42%3.63M | -28.53%3.87M | 2,425.82%4.65M | 513.27%4.47M | 39.84%-11.93M | 288.20%5.41M | -92.46%183.95K | -73.88%729.34K | -169.04%-19.84M |
| Net profit of parent company owners | 0.58%13.96M | 114.97%22.28M | 8.97%14.73M | 21.41%14.03M | 97.44%13.88M | 51.67%-148.89M | 130.11%13.52M | 126.14%11.55M | -32.73%7.03M | -791.91%-308.06M |
| Earning per share | ||||||||||
| Basic earning per share | 0.00%0.02 | 114.98%0.0264 | 0.00%0.02 | 100.00%0.02 | 100.00%0.02 | 51.69%-0.1762 | 140.00%0.02 | -80.00%0.01 | -16.67%0.01 | -780.41%-0.3647 |
| Diluted earning per share | 0.00%0.02 | 114.96%0.0252 | 0.00%0.02 | 100.00%0.02 | 100.00%0.02 | 51.66%-0.1685 | 140.00%0.02 | -80.00%0.01 | -16.67%0.01 | -780.86%-0.3486 |
| Other composite income | -247.61%-2.86M | 426.29%5.09M | -75.25%-2.01M | 125.88%1.84M | 92.54%-823.34K | 100.92%967.81K | -130.84%-1.15M | -467.88%-7.11M | -1,277.54%-11.03M | -393.45%-104.68M |
| Other composite income of parent company owners | -604.24%-4M | 957.31%5.57M | 34.79%-4.58M | 125.09%1.77M | -104.61%-568.26K | 100.49%526.76K | -215.20%-7.03M | -327.92%-7.04M | 1,060.59%12.32M | -377.55%-107.75M |
| Other composite income of minority owners | 546.89%1.14M | -207.92%-475.96K | -56.20%2.58M | 215.76%71.41K | 98.91%-255.07K | -85.62%441.05K | 346.28%5.89M | 94.68%-61.69K | -18,656.54%-23.35M | 127.39%3.07M |
| Total composite income | -19.10%14.18M | 119.40%31.01M | -6.71%16.59M | 342.86%20.51M | 635.80%17.53M | 63.05%-159.86M | 144.70%17.78M | 111.63%4.63M | -123.07%-3.27M | -931.20%-432.59M |
| Total composite income of parent company owners | -25.18%9.96M | 118.77%27.85M | 56.42%10.14M | 250.25%15.79M | -31.19%13.32M | 64.32%-148.36M | 116.72%6.48M | 110.97%4.51M | 68.07%19.35M | -1,993.49%-415.81M |
| Total composite income of minority owners | 0.10%4.22M | 127.45%3.15M | -42.95%6.44M | 3,758.65%4.72M | 118.64%4.22M | 31.47%-11.49M | 1,234.00%11.3M | -90.47%122.26K | -948.07%-22.62M | -155.75%-16.77M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion with explanatory notes |
| Auditor | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) | -- | -- | -- | Asia Pacific (Group) Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting